Annual EBITDA
-$818.79 M
-$158.62 M-24.03%
December 31, 2024
Summary
- As of February 23, 2025, INSM annual EBITDA is -$818.79 million, with the most recent change of -$158.62 million (-24.03%) on December 31, 2024.
- During the last 3 years, INSM annual EBITDA has fallen by -$435.15 million (-113.42%).
- INSM annual EBITDA is now -780.54% below its all-time high of $120.31 million, reached on December 31, 2009.
Performance
INSM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$244.67 M
-$48.21 M-24.54%
December 31, 2024
Summary
- As of February 23, 2025, INSM quarterly EBITDA is -$244.67 million, with the most recent change of -$48.21 million (-24.54%) on December 31, 2024.
- Over the past year, INSM quarterly EBITDA has stayed the same.
- INSM quarterly EBITDA is now -302.14% below its all-time high of $121.04 million, reached on March 31, 2009.
Performance
INSM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$851.72 M
-$82.16 M-10.68%
December 31, 2024
Summary
- As of February 23, 2025, INSM TTM EBITDA is -$851.72 million, with the most recent change of -$82.16 million (-10.68%) on December 31, 2024.
- Over the past year, INSM TTM EBITDA has stayed the same.
- INSM TTM EBITDA is now -807.91% below its all-time high of $120.31 million, reached on December 31, 2009.
Performance
INSM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
INSM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.0% | 0.0% | 0.0% |
| 3 y3 years | -113.4% | 0.0% | 0.0% |
| 5 y5 years | -277.2% | 0.0% | 0.0% |
INSM EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -113.4% | at low | -174.2% | +11.6% | -123.9% | at low |
| 5 y | 5-year | -277.2% | at low | -476.0% | +11.6% | -324.2% | at low |
| alltime | all time | -780.5% | at low | -302.1% | +11.6% | -807.9% | at low |
Insmed Incorporated EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$818.79 M(+24.0%) | -$244.67 M(+24.5%) | -$851.72 M(+10.7%) |
| Sep 2024 | - | -$196.45 M(-29.1%) | -$769.56 M(+8.4%) |
| Jun 2024 | - | -$276.89 M(+107.1%) | -$709.62 M(+8.3%) |
| Mar 2024 | - | -$133.71 M(-17.7%) | -$655.47 M(-0.7%) |
| Dec 2023 | -$660.18 M(+47.6%) | -$162.50 M(+19.0%) | -$660.18 M(+3.3%) |
| Sep 2023 | - | -$136.52 M(-38.7%) | -$639.30 M(+1.7%) |
| Jun 2023 | - | -$222.74 M(+60.9%) | -$628.91 M(+26.7%) |
| Mar 2023 | - | -$138.42 M(-2.3%) | -$496.56 M(+11.0%) |
| Dec 2022 | -$447.37 M(+16.6%) | -$141.63 M(+12.3%) | -$447.37 M(+10.2%) |
| Sep 2022 | - | -$126.13 M(+39.5%) | -$405.91 M(+6.7%) |
| Jun 2022 | - | -$90.39 M(+1.3%) | -$380.33 M(-3.3%) |
| Mar 2022 | - | -$89.22 M(-10.9%) | -$393.13 M(+2.3%) |
| Dec 2021 | -$383.65 M(+53.2%) | -$100.18 M(-0.4%) | -$384.45 M(+2.5%) |
| Sep 2021 | - | -$100.55 M(-2.6%) | -$375.14 M(+14.5%) |
| Jun 2021 | - | -$103.19 M(+28.1%) | -$327.56 M(+19.0%) |
| Mar 2021 | - | -$80.54 M(-11.4%) | -$275.16 M(+9.9%) |
| Dec 2020 | -$250.37 M(+15.3%) | -$90.87 M(+71.6%) | -$250.37 M(+24.0%) |
| Sep 2020 | - | -$52.96 M(+4.3%) | -$201.98 M(+0.6%) |
| Jun 2020 | - | -$50.79 M(-8.9%) | -$200.80 M(-3.3%) |
| Mar 2020 | - | -$55.75 M(+31.2%) | -$207.58 M(-4.4%) |
| Dec 2019 | -$217.07 M(-26.5%) | -$42.48 M(-18.0%) | -$217.07 M(-15.7%) |
| Sep 2019 | - | -$51.78 M(-10.0%) | -$257.61 M(-10.0%) |
| Jun 2019 | - | -$57.56 M(-11.8%) | -$286.31 M(-3.9%) |
| Mar 2019 | - | -$65.24 M(-21.4%) | -$298.01 M(+1.0%) |
| Dec 2018 | -$295.18 M(+59.7%) | -$83.02 M(+3.1%) | -$295.18 M(+7.0%) |
| Sep 2018 | - | -$80.48 M(+16.2%) | -$275.89 M(+15.7%) |
| Jun 2018 | - | -$69.27 M(+11.0%) | -$238.55 M(+12.7%) |
| Mar 2018 | - | -$62.41 M(-2.1%) | -$211.69 M(+14.6%) |
| Dec 2017 | -$184.87 M(+8.6%) | -$63.73 M(+47.7%) | -$184.67 M(-1.3%) |
| Sep 2017 | - | -$43.14 M(+1.7%) | -$187.15 M(+3.8%) |
| Jun 2017 | - | -$42.41 M(+19.8%) | -$180.31 M(+4.1%) |
| Mar 2017 | - | -$35.40 M(-46.5%) | -$173.27 M(+1.8%) |
| Dec 2016 | -$170.24 M(+47.7%) | -$66.21 M(+82.4%) | -$170.24 M(+25.3%) |
| Sep 2016 | - | -$36.29 M(+2.6%) | -$135.88 M(+5.0%) |
| Jun 2016 | - | -$35.37 M(+9.3%) | -$129.36 M(+6.5%) |
| Mar 2016 | - | -$32.37 M(+1.6%) | -$121.44 M(+5.3%) |
| Dec 2015 | -$115.28 M(+33.9%) | -$31.85 M(+7.0%) | -$115.28 M(+8.6%) |
| Sep 2015 | - | -$29.77 M(+8.5%) | -$106.11 M(+6.8%) |
| Jun 2015 | - | -$27.44 M(+4.7%) | -$99.38 M(+5.3%) |
| Mar 2015 | - | -$26.21 M(+15.6%) | -$94.39 M(+9.6%) |
| Dec 2014 | -$86.09 M(+58.8%) | -$22.68 M(-1.5%) | -$86.09 M(+9.2%) |
| Sep 2014 | - | -$23.04 M(+2.6%) | -$78.81 M(+8.9%) |
| Jun 2014 | - | -$22.45 M(+25.3%) | -$72.40 M(+24.8%) |
| Mar 2014 | - | -$17.91 M(+16.3%) | -$58.01 M(+7.0%) |
| Dec 2013 | -$54.20 M(+35.3%) | -$15.40 M(-7.4%) | -$54.20 M(+1.2%) |
| Sep 2013 | - | -$16.63 M(+106.3%) | -$53.57 M(+16.6%) |
| Jun 2013 | - | -$8.06 M(-42.8%) | -$45.96 M(-3.1%) |
| Mar 2013 | - | -$14.11 M(-4.5%) | -$47.45 M(+18.5%) |
| Dec 2012 | -$40.05 M | -$14.77 M(+63.7%) | -$40.05 M(+20.1%) |
| Sep 2012 | - | -$9.02 M(-5.6%) | -$33.34 M(-43.3%) |
| Jun 2012 | - | -$9.55 M(+42.5%) | -$58.82 M(-0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$6.71 M(-16.7%) | -$59.20 M(-0.2%) |
| Dec 2011 | -$59.31 M(+857.7%) | -$8.05 M(-76.7%) | -$59.31 M(+4.1%) |
| Sep 2011 | - | -$34.51 M(+247.4%) | -$56.99 M(+150.7%) |
| Jun 2011 | - | -$9.94 M(+45.8%) | -$22.74 M(+72.6%) |
| Mar 2011 | - | -$6.81 M(+18.8%) | -$13.18 M(+112.8%) |
| Dec 2010 | -$6.19 M(-105.1%) | -$5.74 M(+2167.2%) | -$6.19 M(+1569.3%) |
| Sep 2010 | - | -$253.00 K(-32.5%) | -$371.00 K(+165.0%) |
| Jun 2010 | - | -$375.00 K(-319.3%) | -$140.00 K(-74.5%) |
| Mar 2010 | - | $171.00 K(+98.8%) | -$550.00 K(-100.5%) |
| Dec 2009 | $120.31 M(-1000.0%) | $86.00 K(-490.9%) | $120.31 M(+3.1%) |
| Sep 2009 | - | -$22.00 K(-97.2%) | $116.72 M(+1.4%) |
| Jun 2009 | - | -$785.00 K(-100.6%) | $115.11 M(+3.0%) |
| Mar 2009 | - | $121.04 M(-3550.3%) | $111.73 M(-908.8%) |
| Dec 2008 | -$13.37 M(-33.3%) | -$3.51 M(+114.6%) | -$13.81 M(+2.3%) |
| Sep 2008 | - | -$1.64 M(-60.7%) | -$13.50 M(-15.1%) |
| Jun 2008 | - | -$4.17 M(-7.6%) | -$15.90 M(+11.8%) |
| Mar 2008 | - | -$4.51 M(+40.9%) | -$14.22 M(-29.0%) |
| Dec 2007 | -$20.03 M(-60.7%) | -$3.20 M(-20.7%) | -$20.03 M(-47.0%) |
| Sep 2007 | - | -$4.03 M(+62.4%) | -$37.77 M(-18.6%) |
| Jun 2007 | - | -$2.48 M(-75.9%) | -$46.37 M(-12.7%) |
| Mar 2007 | - | -$10.32 M(-50.7%) | -$53.13 M(+4.2%) |
| Dec 2006 | -$51.00 M(+250.9%) | -$20.93 M(+65.7%) | -$51.00 M(+62.0%) |
| Sep 2006 | - | -$12.64 M(+36.7%) | -$31.48 M(+49.4%) |
| Jun 2006 | - | -$9.24 M(+12.8%) | -$21.07 M(+20.9%) |
| Mar 2006 | - | -$8.19 M(+482.0%) | -$17.43 M(+19.9%) |
| Dec 2005 | -$14.54 M(-46.9%) | -$1.41 M(-36.8%) | -$14.54 M(-23.5%) |
| Sep 2005 | - | -$2.23 M(-60.2%) | -$19.01 M(-22.2%) |
| Jun 2005 | - | -$5.60 M(+5.8%) | -$24.42 M(-12.4%) |
| Mar 2005 | - | -$5.30 M(-9.9%) | -$27.87 M(+1.7%) |
| Dec 2004 | -$27.39 M(+161.1%) | -$5.88 M(-23.0%) | -$27.39 M(+14.1%) |
| Sep 2004 | - | -$7.64 M(-15.6%) | -$24.00 M(+27.6%) |
| Jun 2004 | - | -$9.05 M(+87.7%) | -$18.80 M(+44.2%) |
| Mar 2004 | - | -$4.82 M(+93.7%) | -$13.04 M(+24.3%) |
| Dec 2003 | -$10.49 M(-69.3%) | -$2.49 M(+1.8%) | -$10.49 M(-60.6%) |
| Sep 2003 | - | -$2.44 M(-25.6%) | -$26.60 M(+1.0%) |
| Jun 2003 | - | -$3.29 M(+44.6%) | -$26.34 M(-12.8%) |
| Mar 2003 | - | -$2.27 M(-87.8%) | -$30.23 M(-11.5%) |
| Dec 2002 | -$34.15 M(-11.6%) | -$18.60 M(+750.6%) | -$34.15 M(+34.9%) |
| Sep 2002 | - | -$2.19 M(-69.5%) | -$25.32 M(-20.2%) |
| Jun 2002 | - | -$7.17 M(+15.7%) | -$31.74 M(-6.2%) |
| Mar 2002 | - | -$6.19 M(-36.7%) | -$33.85 M(-12.4%) |
| Dec 2001 | -$38.64 M(+27.5%) | -$9.78 M(+13.5%) | -$38.64 M(-398.4%) |
| Sep 2001 | - | -$8.61 M(-7.1%) | $12.95 M(-20.7%) |
| Jun 2001 | - | -$9.27 M(-15.7%) | $16.34 M(-154.6%) |
| Mar 2001 | - | -$10.99 M(-126.3%) | -$29.90 M(-1.3%) |
| Dec 2000 | -$30.31 M(+276.9%) | $41.82 M(-900.2%) | -$30.31 M(-58.0%) |
| Sep 2000 | - | -$5.23 M(-90.6%) | -$72.13 M(+7.8%) |
| Jun 2000 | - | -$55.51 M(+387.0%) | -$66.90 M(+412.5%) |
| Mar 2000 | - | -$11.40 M(+587.8%) | -$13.05 M(+305.7%) |
| Dec 1999 | -$8.04 M | - | - |
| Jun 1999 | - | -$1.66 M(+6.1%) | -$3.22 M(+106.1%) |
| Mar 1999 | - | -$1.56 M | -$1.56 M |
FAQ
- What is Insmed Incorporated annual EBITDA?
- What is the all time high annual EBITDA for Insmed Incorporated?
- What is Insmed Incorporated annual EBITDA year-on-year change?
- What is Insmed Incorporated quarterly EBITDA?
- What is the all time high quarterly EBITDA for Insmed Incorporated?
- What is Insmed Incorporated quarterly EBITDA year-on-year change?
- What is Insmed Incorporated TTM EBITDA?
- What is the all time high TTM EBITDA for Insmed Incorporated?
- What is Insmed Incorporated TTM EBITDA year-on-year change?
What is Insmed Incorporated annual EBITDA?
The current annual EBITDA of INSM is -$818.79 M
What is the all time high annual EBITDA for Insmed Incorporated?
Insmed Incorporated all-time high annual EBITDA is $120.31 M
What is Insmed Incorporated annual EBITDA year-on-year change?
Over the past year, INSM annual EBITDA has changed by -$158.62 M (-24.03%)
What is Insmed Incorporated quarterly EBITDA?
The current quarterly EBITDA of INSM is -$244.67 M
What is the all time high quarterly EBITDA for Insmed Incorporated?
Insmed Incorporated all-time high quarterly EBITDA is $121.04 M
What is Insmed Incorporated quarterly EBITDA year-on-year change?
Over the past year, INSM quarterly EBITDA has changed by $0.00 (0.00%)
What is Insmed Incorporated TTM EBITDA?
The current TTM EBITDA of INSM is -$851.72 M
What is the all time high TTM EBITDA for Insmed Incorporated?
Insmed Incorporated all-time high TTM EBITDA is $120.31 M
What is Insmed Incorporated TTM EBITDA year-on-year change?
Over the past year, INSM TTM EBITDA has changed by $0.00 (0.00%)